• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of anaphylaxis in patients receiving beta-blocker drugs.

作者信息

Toogood J H

机构信息

Allergy Clinic, Victoria Hospital, London, Ontario, Canada.

出版信息

J Allergy Clin Immunol. 1988 Jan;81(1):1-5. doi: 10.1016/0091-6749(88)90212-6.

DOI:10.1016/0091-6749(88)90212-6
PMID:2892872
Abstract
摘要

相似文献

1
Risk of anaphylaxis in patients receiving beta-blocker drugs.接受β受体阻滞剂药物治疗的患者发生过敏反应的风险。
J Allergy Clin Immunol. 1988 Jan;81(1):1-5. doi: 10.1016/0091-6749(88)90212-6.
2
Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?β受体阻滞剂真的会增加免疫治疗期间过敏反应的风险吗？
Curr Allergy Asthma Rep. 2008 Mar;8(1):37-44. doi: 10.1007/s11882-008-0008-8.
3
Beta-blockers and anaphylaxis: are the risks overstated?
J Allergy Clin Immunol. 2005 Oct;116(4):931-3; author reply 933-6. doi: 10.1016/j.jaci.2005.06.019.
4
Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis.患有心脏病和花生诱导性过敏反应的患者应该使用β受体阻滞剂吗？一项决策分析。
J Allergy Clin Immunol. 2004 May;113(5):977-82. doi: 10.1016/j.jaci.2004.02.043.
5
Beta-blocker therapy and the risk of anaphylaxis.β受体阻滞剂治疗与过敏反应风险
CMAJ. 1987 May 1;136(9):929-33.
6
Are ACE Inhibitors and Beta-blockers Dangerous in Patients at Risk for Anaphylaxis?血管紧张素转换酶抑制剂和β受体阻滞剂在过敏反应风险患者中是否危险？
J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1207-1211. doi: 10.1016/j.jaip.2017.04.033. Epub 2017 May 25.
7
Beta-blocker therapy and the risk of anaphylaxis.β受体阻滞剂治疗与过敏反应风险
CMAJ. 1987 Sep 1;137(5):370-1.
8
Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders.造影剂引起类过敏反应的风险升高与β受体阻滞剂暴露和心血管疾病均有关。
Arch Intern Med. 1993 Sep 13;153(17):2033-40.
9
Beta-blocker therapy and the risk of anaphylaxis.β受体阻滞剂治疗与过敏反应风险
CMAJ. 1987 Oct 1;137(7):587-8, 590-1.
10
Current review of anaphylaxis and its relationship to asthma.过敏反应及其与哮喘关系的当前综述。
Allerg Immunol (Paris). 1991 Dec;23(10):417-20.

引用本文的文献

1
[Not Available].[无可用内容]
Allergo J. 2021;30(1):20-49. doi: 10.1007/s15007-020-4750-0. Epub 2021 Feb 12.
2
Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE).过敏反应急性治疗与管理指南（S2k）：2021年更新版：德国过敏和临床免疫学会（DGAKI）、德国过敏症专科医生医学协会（AeDA）、儿科过敏与环境医学学会（GPA）、德国过敏与环境医学学会（DAAU）、德国儿科医生专业协会（BVKJ）、新生儿学与儿科重症监护学会（GNPI）、德国皮肤病学会（DDG）、奥地利过敏与免疫学会（ÖGAI）、瑞士过敏与免疫学会（SGAI）、德国麻醉学与重症监护医学学会（DGAI）、德国药理学会（DGP）、德国呼吸学会（DGP）、患者组织德国过敏与哮喘协会（DAAB）、德国过敏反应培训与教育工作组（AGATE）制定的S2k指南
Allergo J Int. 2021;30(1):1-25. doi: 10.1007/s40629-020-00158-y. Epub 2021 Jan 28.
3
Outpatient Emergencies: Anaphylaxis.门诊急症：过敏反应
Med Clin North Am. 2017 May;101(3):521-536. doi: 10.1016/j.mcna.2016.12.003. Epub 2017 Mar 2.
4
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.过敏反应学诊断和治疗程序的风险与安全要求：世界过敏组织声明
World Allergy Organ J. 2016 Oct 12;9(1):33. doi: 10.1186/s40413-016-0122-3. eCollection 2016.
5
Management and Prevention of Anaphylaxis.过敏反应的管理与预防
F1000Res. 2015 Dec 22;4. doi: 10.12688/f1000research.7181.1. eCollection 2015.
6
Perioperative anaphylaxis.围手术期过敏反应。
Curr Allergy Asthma Rep. 2014 Aug;14(8):452. doi: 10.1007/s11882-014-0452-6.
7
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.美国食物过敏诊断与管理指南：NIAID 赞助专家组报告。
J Allergy Clin Immunol. 2010 Dec;126(6 Suppl):S1-58. doi: 10.1016/j.jaci.2010.10.007.
8
Navigating the updated anaphylaxis parameters.解读更新后的过敏反应参数
Allergy Asthma Clin Immunol. 2007 Jun 15;3(2):40-9. doi: 10.1186/1710-1492-3-2-40.
9
Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?β受体阻滞剂真的会增加免疫治疗期间过敏反应的风险吗？
Curr Allergy Asthma Rep. 2008 Mar;8(1):37-44. doi: 10.1007/s11882-008-0008-8.
10
Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin.对459例接受静脉注射免疫球蛋白的原发性抗体缺陷患者发生的不良反应进行前瞻性审计。
Clin Exp Immunol. 2003 Aug;133(2):247-51. doi: 10.1046/j.1365-2249.2003.02199.x.